225 related articles for article (PubMed ID: 11846487)
1. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A
Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487
[TBL] [Abstract][Full Text] [Related]
2. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D
Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713
[TBL] [Abstract][Full Text] [Related]
3. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
4. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition.
DeBaun MR; Ess J; Saunders S
Mol Genet Metab; 2001 Apr; 72(4):279-86. PubMed ID: 11286501
[TBL] [Abstract][Full Text] [Related]
5. glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development.
Paine-Saunders S; Viviano BL; Zupicich J; Skarnes WC; Saunders S
Dev Biol; 2000 Sep; 225(1):179-87. PubMed ID: 10964473
[TBL] [Abstract][Full Text] [Related]
6. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
Cano-Gauci DF; Song HH; Yang H; McKerlie C; Choo B; Shi W; Pullano R; Piscione TD; Grisaru S; Soon S; Sedlackova L; Tanswell AK; Mak TW; Yeger H; Lockwood GA; Rosenblum ND; Filmus J
J Cell Biol; 1999 Jul; 146(1):255-64. PubMed ID: 10402475
[TBL] [Abstract][Full Text] [Related]
7. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
Lin H; Huber R; Schlessinger D; Morin PJ
Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067
[TBL] [Abstract][Full Text] [Related]
8. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification.
Viviano BL; Silverstein L; Pflederer C; Paine-Saunders S; Mills K; Saunders S
Dev Biol; 2005 Jun; 282(1):152-62. PubMed ID: 15936336
[TBL] [Abstract][Full Text] [Related]
9. Overgrowth syndromes and genomic imprinting: from mouse to man.
Li M; Squire JA; Weksberg R
Clin Genet; 1998 Mar; 53(3):165-70. PubMed ID: 9630066
[TBL] [Abstract][Full Text] [Related]
10. Genotype/phenotype correlations of males affected by Simpson-Golabi-Behmel syndrome with GPC3 gene mutations: patient report and review of the literature.
Mariani S; Iughetti L; Bertorelli R; Coviello D; Pellegrini M; Forabosco A; Bernasconi S
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):225-32. PubMed ID: 12713262
[TBL] [Abstract][Full Text] [Related]
11. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
Xuan JY; Hughes-Benzie RM; MacKenzie AE
J Med Genet; 1999 Jan; 36(1):57-8. PubMed ID: 9950367
[TBL] [Abstract][Full Text] [Related]
12. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
Murthy SS; Shen T; De Rienzo A; Lee WC; Ferriola PC; Jhanwar SC; Mossman BT; Filmus J; Testa JR
Oncogene; 2000 Jan; 19(3):410-6. PubMed ID: 10656689
[TBL] [Abstract][Full Text] [Related]
13. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
Hartwig S; Hu MC; Cella C; Piscione T; Filmus J; Rosenblum ND
Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
[TBL] [Abstract][Full Text] [Related]
14. Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families.
Hughes-Benzie RM; Pilia G; Xuan JY; Hunter AG; Chen E; Golabi M; Hurst JA; Kobori J; Marymee K; Pagon RA; Punnett HH; Schelley S; Tolmie JL; Wohlferd MM; Grossman T; Schlessinger D; MacKenzie AE
Am J Med Genet; 1996 Dec; 66(2):227-34. PubMed ID: 8958336
[TBL] [Abstract][Full Text] [Related]
15. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome.
Li M; Shuman C; Fei YL; Cutiongco E; Bender HA; Stevens C; Wilkins-Haug L; Day-Salvatore D; Yong SL; Geraghty MT; Squire J; Weksberg R
Am J Med Genet; 2001 Aug; 102(2):161-8. PubMed ID: 11477610
[TBL] [Abstract][Full Text] [Related]
16. Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling.
Sung YK; Hwang SY; Farooq M; Kim JC; Kim MK
Exp Mol Med; 2003 Aug; 35(4):257-62. PubMed ID: 14508064
[TBL] [Abstract][Full Text] [Related]
17. Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations.
Yano S; Baskin B; Bagheri A; Watanabe Y; Moseley K; Nishimura A; Matsumoto N; Ray PN
Clin Genet; 2011 Nov; 80(5):466-71. PubMed ID: 20950395
[TBL] [Abstract][Full Text] [Related]
18. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).
Liu JP; Baker J; Perkins AS; Robertson EJ; Efstratiadis A
Cell; 1993 Oct; 75(1):59-72. PubMed ID: 8402901
[TBL] [Abstract][Full Text] [Related]
19. Glypican-3 expression is silenced in human breast cancer.
Xiang YY; Ladeda V; Filmus J
Oncogene; 2001 Nov; 20(50):7408-12. PubMed ID: 11704870
[TBL] [Abstract][Full Text] [Related]
20. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes.
Eggenschwiler J; Ludwig T; Fisher P; Leighton PA; Tilghman SM; Efstratiadis A
Genes Dev; 1997 Dec; 11(23):3128-42. PubMed ID: 9389646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
